Navigation Links
Mother's milk a gift that keeps on giving
Date:9/14/2007

GALVESTON, Texas Extensive medical research shows that mothers milk satisfies babies nutritional needs far better than any manufactured infant formula. It also protects babies against many common infectious diseases and certain inflammatory diseases, and probably helps lower the risk of a child later developing diabetes, lymphoma and some types of leukemia.

These conclusions appear in a major new review of the medical literature published this month entitled Benefits and Risks of Breastfeeding.

The article, published in the current issue of Advances in Pediatrics (and available online at http://www.sciencedirect.com/science/journal/00653101), surveys both risks and benefits associated with breastfeeding. Many mothers and medical professionals may not understand that a great number of protective factors unique to human milk are provided by breastfeeding and how much breastfeedings benefits outweigh its rare but often well-publicized risks, said Dr. Armond Goldman, senior author of the paper and professor emeritus of pediatrics at the University of Texas Medical Branch at Galveston.

In the United States, this misunderstanding of benefits versus risks in addition to social factors such as less generous maternity leave policies and poor preventive health care for much of the population has helped keep the rates of initiation and continuation of breastfeeding in the U.S. lower than those in most developed countries, Goldman said.

Coincidentally, the paper appeared online just before the Washington Post reported on Aug. 31 that lobbyists for the infant formula industry had succeeded in getting the federal Department of Health and Human Services to tone down a government-sponsored attention-grabbing advertising campaign in 2004 designed to convince mothers that their babies faced real health risks if they did not breastfeed.

A congressional investiga
'/>"/>

Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Allergies are related to mothers menses
2. Mothers with periodontitis may deliver premature babies
3. Changing Partners may put Expectant Mothers at Risk
4. Link Between Mothers Depression and Violence in Children
5. Depressed Mothers Found To Influence Their Child’s Behavio
6. Risk of preeclampsia in pregnant mothers may be inherited
7. Low hemoglobin may make mothers bond less with their babies
8. Pregnant mothers dental health can lead to pre-term babies
9. Mothers diet in pregnancy and after can prevent daughter’s breast cancer
10. Overweight mothers overfeed obese children
11. Donated Mothers Milk To Hit The Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... ... According to the The Media Post on July 9th teenagers ... medicinal use are more likely to abuse the substance. A recent study conducted by ... beneficial are more apt to use the substance, as opposed to their peers who ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... therapeutic development for Atherosclerosis. Atherosclerosis is a slow, progressive disease that may start ... to produce first-in-class and best-in-class products. Complete report on Atherosclerosis Pipeline with 78 ...
(Date:7/29/2015)... ... July 29, 2015 , ... The NCCA re-accredited the Commission ... November 30, 2019, during its recent meeting. , The Commission received renewal of ... compliance with the NCCA’s Standards for the Accreditation of Certification Programs. NCCA ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... changed its name in July to Kalamazoo Strength & Conditioning. , The name ... and “reflects the evolution of our training center over the past three years,” ...
(Date:7/29/2015)... ... , ... Today marks a significant achievement in bringing new monies into early ... led by a group of experienced investors, has tapped into an investor community passionate ... be a part of the fund. The Sofia Fund II is now closed ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Sofia Fund Surpasses Investor Goals 2
... published the first comprehensive review of evidence on pneumococcal ... available in the on-line edition of the journal Lancet ... risk of pneumococcal infection by up to 40 fold, ... the PCV, and that the vaccine can protect HIV-infected ...
... San Diego have developed a novel computer technique to ... study, reported November 30 in PLoS Computational Biology relates ... Receptor Modulators (SERMs), which includes tamoxifen, the most prescribed ... side effects account for one-third of all drug development ...
... President of International Operations, MONROVIA, Calif., Nov. ... a leading developer, manufacturer and marketer of,minimally invasive ... has been named President and Chief Executive Officer. ... the annual shareholder,s,meeting in May 2007, replaces David ...
... Nov. 28 Novant Health(R) today announced ... leader,in developing and manufacturing medical devices for ... implement the Cardiocom System in its,Presbyterian Heart ... Hospital is one of the largest healthcare ...
... ASHBURN, Va., Nov. 28 Innocoll, Inc. announced ... that pursuant to,Rule 51(4) EPC, the European Patent ... applications which are both based on its proprietary,CollaRx ... Treatment of,Wounds" and Patent No. 1265648 entitled "Novel ...
... Corporation,("Sosei"; TSE Mothers Index: 4565), a biopharmaceutical company, ... UK Medicines and,Healthcare products Regulatory Agency (MHRA) for ... sublingual spray (AD 923), an opioid,analgesic for the ... trial authorisation (CTA) covers two multi-centre pivotal,Phase III ...
Cached Medicine News:Health News:Pneumococcal conjugate vaccines can improve the lives of HIV-infected children 2Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 2Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 3Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 4Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 5Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 6Health News:Novant Health(R) Selects Cardiocom(R) to Provide Telemonitoring for Presbyterian Hospital Heart Failure Program 2Health News:Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology 2Health News:Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology 3Health News:Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology 4Health News:Sosei Announces Approval to Start AD 923 Phase III Studies in Europe 2
(Date:7/29/2015)... SAN DIEGO , July 29, 2015 /PRNewswire/ ... Thursday, July 23, called the Alvarado Spine & ... orthopedic surgery and rehabilitation, focusing on spinal surgery ... method of patient care takes a patient experience-focused ... whatever clothing they feel comfortable in, rather than ...
(Date:7/29/2015)... FOREST, Calif. , July 29, 2015 ... ("Cryoport" or the "Company"), the leading provider ... life sciences industry, serving markets including immunotherapies, ... vaccine manufacturers, animal health, and reproductive medicine, ... the sale of common stock and warrants (the ...
(Date:7/29/2015)... 29, 2015  Ortho-Clinical Diagnostics, Inc. (OCD) today announced ... The assays address a range of important tests for ... troponin I. The scientific posters will be delivered during ... to be held July 26 - 30 in ... Clinical Diagnostics is emerging stronger than ever since becoming ...
Breaking Medicine Technology:The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3
... Texas--(BUSINESS WIRE)--Apr 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:RPRX) ... of Proellex(TM), an oral drug being developed to,relieve ... with Proellex results in a statistically highly,significant improvement ... well tolerated., Study Details and Results , This ...
... Arrowhead Research,Corporation (NASDAQ: ARWR) announced the publication ... a study,demonstrating the anti-proliferative effect of the ... its lead anti-cancer,compound, CALAA-01., The paper, entitled ... Reduce Cell Proliferation In vitro and In,vivo", ...
Cached Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3
... Health Record (EHR/EMR) and ... Specialties that we currently ... Cardiology, Dermatology, Family Medicine, ... Neurosurgery, Obstetrics and Gynecology, ...
... Software developed a touchscreen EHR and is ... a user can choose to use a ... maintain eye contact while recording encounter results. ... EHR also runs on a pen tablet ...
Dairylands Health Information Management solutions provides healthcare organizations a suite of integrated applications for managing patient records, optimizing reimbursement and regulatory complianc...
... WEBeDoctor® Physician-office® is ... for physicians, (Solo practice, ... care), to complete their ... practice. It is a ...
Medicine Products: